These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 33615463)
41. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review. Kakasis A; Panitsa G Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954 [TBL] [Abstract][Full Text] [Related]
42. [Possibilities of bacteriophage therapy]. Skurnik M; Kiljunen S Duodecim; 2016; 132(8):712-9. PubMed ID: 27244930 [TBL] [Abstract][Full Text] [Related]
47. [Immunophage synergy is required for successful pulmonary phage therapy]. De Jode M; Roach D; Debarbieux L Med Sci (Paris); 2018 Apr; 34(4):291-293. PubMed ID: 29658466 [No Abstract] [Full Text] [Related]
48. [Phage therapy: a realistic weapon against multidrug resistant bacteria]. Dufour N; Debarbieux L Med Sci (Paris); 2017 Apr; 33(4):410-416. PubMed ID: 28497737 [TBL] [Abstract][Full Text] [Related]
49. Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen. Roach DR; Leung CY; Henry M; Morello E; Singh D; Di Santo JP; Weitz JS; Debarbieux L Cell Host Microbe; 2017 Jul; 22(1):38-47.e4. PubMed ID: 28704651 [TBL] [Abstract][Full Text] [Related]
50. Bacteriophage therapy for management of bacterial infections in veterinary practice: what was once old is new again. Squires RA N Z Vet J; 2018 Sep; 66(5):229-235. PubMed ID: 29925297 [TBL] [Abstract][Full Text] [Related]
52. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts. Royer S; Morais AP; da Fonseca Batistão DW Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609 [TBL] [Abstract][Full Text] [Related]
53. Fitness Trade-Offs between Phage and Antibiotic Sensitivity in Phage-Resistant Variants: Molecular Action and Insights into Clinical Applications for Phage Therapy. Fujiki J; Nakamura K; Nakamura T; Iwano H Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958612 [TBL] [Abstract][Full Text] [Related]
54. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences. Chanishvili N Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515 [TBL] [Abstract][Full Text] [Related]
55. Pharmacological limitations of phage therapy. Nilsson AS Ups J Med Sci; 2019 Nov; 124(4):218-227. PubMed ID: 31724901 [TBL] [Abstract][Full Text] [Related]
56. The disparate effects of bacteriophages on antibiotic-resistant bacteria. Torres-Barceló C Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018 [TBL] [Abstract][Full Text] [Related]
59. Community-acquired pneumonia: aetiology, antibiotic resistance and prospects of phage therapy. Sheam MM; Syed SB; Nain Z; Tang SS; Paul DK; Ahmed KR; Biswas SK J Chemother; 2020 Dec; 32(8):395-410. PubMed ID: 32820711 [TBL] [Abstract][Full Text] [Related]
60. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR mBio; 2017 Oct; 8(5):. PubMed ID: 29089428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]